Long-term survey reveals worsening death rate for oral cancer in Queensland

by James Cook UniversityTrends in number of cases and number of deaths during the 36-year period. Credit:Journal of Oral Pathology & Medicine(2023). DOI: 10.1111/jop.13421A study

Updated on: January 30,2024

Long-term survey reveals worsening death rate for oral cancer in Queensland

by James Cook UniversityTrends in number of cases and number of deaths during the 36-year period. Credit:Journal of Oral Pathology & Medicine(2023). DOI: 10.1111/jop.13421A study

Updated on:January 30,2024

Study shows checkpoint inhibitor prolongs survival in patients with certain head and neck cancers

by Anne Doerr,Yale UniversityCredit: stock.adobe.comThe checkpoint inhibitor pembrolizumab (Keytruda) increases the survival time of patients with advanced head and neck cancers, according to a

Updated on: May 31,2024

Study shows checkpoint inhibitor prolongs survival in patients with certain head and neck cancers

by Anne Doerr,Yale UniversityCredit: stock.adobe.comThe checkpoint inhibitor pembrolizumab (Keytruda) increases the survival time of patients with advanced head and neck cancers, according to a

Updated on:May 31,2024

Study uncovers epigenetic source of resistance to targeted therapy in EGFR-mutant lung cancer

by Dana-Farber Cancer InstituteCredit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.07.005When lung cancers driven by mutations in the EGFR gene become resistant to osimertinib or othe

Updated on: February 01,2024

Study uncovers epigenetic source of resistance to targeted therapy in EGFR-mutant lung cancer

by Dana-Farber Cancer InstituteCredit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.07.005When lung cancers driven by mutations in the EGFR gene become resistant to osimertinib or othe

Updated on:February 01,2024

Studies give new insights on immunotherapy in elderly patients with advanced NSCLC

by European Society for Medical OncologyTwo studies to be reported at ELCC 2019 provide new insights on the efficacy and safety of immunotherapy in elderly patients with advanced non-small-cell l

Updated on: May 31,2024

Studies give new insights on immunotherapy in elderly patients with advanced NSCLC

by European Society for Medical OncologyTwo studies to be reported at ELCC 2019 provide new insights on the efficacy and safety of immunotherapy in elderly patients with advanced non-small-cell l

Updated on:May 31,2024

Researchers discover new pathways to activate dendritic cells, produce strong anti-tumor immunity

by H. Lee Moffitt Cancer Center & Research InstituteArtistic rendering of the surface of a human dendritic cell illustrating sheet-like processes that fold back onto the membrane surface. Cre

Updated on: January 30,2024

Researchers discover new pathways to activate dendritic cells, produce strong anti-tumor immunity

by H. Lee Moffitt Cancer Center & Research InstituteArtistic rendering of the surface of a human dendritic cell illustrating sheet-like processes that fold back onto the membrane surface. Cre

Updated on:January 30,2024

1999 to 2018 saw increase in cancer survivors with functional limitation, finds research

by Elana GotkineFrom 1999 to 2018, there was a more than twofold increase in the number of cancer survivors reporting functional limitations, according to a research letter published online May 11 in&

Updated on: January 23,2024

1999 to 2018 saw increase in cancer survivors with functional limitation, finds research

by Elana GotkineFrom 1999 to 2018, there was a more than twofold increase in the number of cancer survivors reporting functional limitations, according to a research letter published online May 11 in&

Updated on:January 23,2024

Specialized immune cells carry potential for new cancer immunotherapies

byLeiden UniversityTumor-infiltrating Vδ1 and Vδ3 T cell subsets display hallmarks of cytotoxic activity in MMR-d colon cancers. a, UMAP embedding showing the clustering of γδ T cells (n = 4,442

Updated on: January 23,2024

Specialized immune cells carry potential for new cancer immunotherapies

byLeiden UniversityTumor-infiltrating Vδ1 and Vδ3 T cell subsets display hallmarks of cytotoxic activity in MMR-d colon cancers. a, UMAP embedding showing the clustering of γδ T cells (n = 4,442

Updated on:January 23,2024

Researchers key to advance care planning with cancer clinical trial patients

by University of Pennsylvania School of NursingConnie M. Ulrich, PhD, RN, FAAN, the Lillian S. Brunner Chair in Medical and Surgical Nursing at the University of Pennsylvania School of Nursing (P

Updated on: June 15,2024

Researchers key to advance care planning with cancer clinical trial patients

by University of Pennsylvania School of NursingConnie M. Ulrich, PhD, RN, FAAN, the Lillian S. Brunner Chair in Medical and Surgical Nursing at the University of Pennsylvania School of Nursing (P

Updated on:June 15,2024

No increased cancer risk found in rheumatology patients with history of malignancy taking DMARDS and TNF inhibitors

byAmerican College of RheumatologyFlowchart of patients included in the study. Credit: Cancer Risk with Biologic and Targeted Synthetic DMARDs in Patients with Rheumatic Diseases and Previous Ma

Updated on: January 29,2024

No increased cancer risk found in rheumatology patients with history of malignancy taking DMARDS and TNF inhibitors

byAmerican College of RheumatologyFlowchart of patients included in the study. Credit: Cancer Risk with Biologic and Targeted Synthetic DMARDs in Patients with Rheumatic Diseases and Previous Ma

Updated on:January 29,2024

Artificial intelligence-aided colonoscopy does not increase cancer detection

by Elana GotkineAdenoma and polyp detection rates (ADR/PDR) are lower with use of artificial intelligence-aided colonoscopy (AIAC), according to a study published in the November issue ofThe&nbs

Updated on: January 02,2024

Artificial intelligence-aided colonoscopy does not increase cancer detection

by Elana GotkineAdenoma and polyp detection rates (ADR/PDR) are lower with use of artificial intelligence-aided colonoscopy (AIAC), according to a study published in the November issue ofThe&nbs

Updated on:January 02,2024

Study: Innovative pancreatic cancer treatment may rev up immune system

by University of Rochester Medical CenterImmune cells (orange) and blood vessels (green) inside a tumor. Credit: University of Rochester Medical CenterA University of Rochester Wilmot Cancer Inst

Updated on: March 01,2024

Study: Innovative pancreatic cancer treatment may rev up immune system

by University of Rochester Medical CenterImmune cells (orange) and blood vessels (green) inside a tumor. Credit: University of Rochester Medical CenterA University of Rochester Wilmot Cancer Inst

Updated on:March 01,2024

New hormonal agent may slow progression of early-stage prostate cancer during active surveillance

byWolters Kluwer HealthPositive biopsy-free survival with 95% confidence limits (shaded gray areas). Credit:Journal of Urology(2023). DOI: 10.1097/JU.0000000000003038For men with ear

Updated on: January 12,2024

New hormonal agent may slow progression of early-stage prostate cancer during active surveillance

byWolters Kluwer HealthPositive biopsy-free survival with 95% confidence limits (shaded gray areas). Credit:Journal of Urology(2023). DOI: 10.1097/JU.0000000000003038For men with ear

Updated on:January 12,2024